Mounjaro 15 MG/0.5 ML pen 0.5ML
Ended Awarded Last action
- Contract number
- SPE2DR26FP9DN
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3 Part of Cencora, Inc.
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $20,487
Award facts
- Contract value 100% obligated
- $20,486.93 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency (DLA) awarded a delivery order valued at $20,486.93 to AmerisourceBergen Drug Corp for the supply of Mounjaro (tirzepatide) 15 mg/0.5 mL in pre-filled pen format. This competitive award, issued on February 4, 2026, with an ultimate completion date of February 5, 2026, carries firm fixed pricing and involves no set-aside designation. The pharmaceutical product will be delivered to AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order represents a task order under the company's larger Indefinite Delivery Contract with DLA Troop Support Medical, a $999,999,999.00 comprehensive pharmaceutical supply vehicle extending through December 2026.
AmerisourceBergen Drug Corp, a subsidiary of parent company Cencora, Inc., serves as a critical pharmaceutical distributor for federal military and veteran healthcare systems. The company maintains extensive federal contract experience supplying a diverse portfolio of pharmaceutical products across multiple therapeutic domains to the Defense Health Agency, U.S. Coast Guard, and other government healthcare entities. Mounjaro, a diabetes medication, aligns with AmerisourceBergen's demonstrated capability in delivering specialty pharmaceuticals and medical commodities required by military treatment facilities and federal medical institutions worldwide. The compact timeline and firm fixed-price structure reflect standard procurement practices for routine pharmaceutical supply orders under established indefinite delivery vehicles.
Quick answers
Who was awarded contract SPE2DR26FP9DN?
SPE2DR26FP9DN was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on February 4, 2026.
How much is contract SPE2DR26FP9DN worth?
The government has obligated $20,487 on SPE2DR26FP9DN.
Is contract SPE2DR26FP9DN an order under another contract?
Yes. SPE2DR26FP9DN is a delivery order under SPE2DR25D3005, an indefinite delivery contract.
Was contract SPE2DR26FP9DN competed?
The extent of competition for SPE2DR26FP9DN was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award